Genomic analysis of head and neck squamous cell carcinoma cell lines and human tumors: a rational approach to preclinical model selection.
about
Tumor-Derived Cell Lines as Molecular Models of Cancer PharmacogenomicsCetuximab Reconstitutes Pro-Inflammatory Cytokine Secretions and Tumor-Infiltrating Capabilities of sMICA-Inhibited NK Cells in HNSCC Tumor Spheroids.FGFR1 Expression Levels Predict BGJ398 Sensitivity of FGFR1-Dependent Head and Neck Squamous Cell CancersNew insights into the mechanism of DNA mismatch repairHCS campaign to identify selective inhibitors of IL-6-induced STAT3 pathway activation in head and neck cancer cell linesErlotinib, erlotinib-sulindac versus placebo: a randomized, double-blind, placebo-controlled window trial in operable head and neck cancer.The head and neck cancer cell oncogenome: a platform for the development of precision molecular therapiesSequencing the head and neck cancer genome: implications for therapyMEK Inhibitor PD-0325901 Overcomes Resistance to PI3K/mTOR Inhibitor PF-5212384 and Potentiates Antitumor Effects in Human Head and Neck Squamous Cell Carcinoma.Production of Uniform 3D Microtumors in Hydrogel Microwell Arrays for Measurement of Viability, Morphology, and Signaling Pathway ActivationProteomic Characterization of Head and Neck Cancer Patient-Derived Xenografts.Carboxyl-Terminal Modulator Protein Positively Acts as an Oncogenic Driver in Head and Neck Squamous Cell Carcinoma via Regulating Akt phosphorylationGenetically-defined novel oral squamous cell carcinoma cell lines for the development of molecular therapies.Molecular analysis of urothelial cancer cell lines for modeling tumor biology and drug response.Cytogenetic alterations and their molecular genetic correlates in head and neck squamous cell carcinoma: a next generation window to the biology of disease.Personalizing Medicine in Head and Neck Squamous Cell Carcinoma: The Rationale for Combination TherapiesDistinctive behaviour of live biopsy-derived carcinoma cells unveiled using coherence-controlled holographic microscopy.Analysis of renal cancer cell lines from two major resources enables genomics-guided cell line selection.Differential pattern of HIF-1α expression in HNSCC cancer stem cells after carbon ion or photon irradiation: one molecular explanation of the oxygen effect.Cotargeting mTORC and EGFR Signaling as a Therapeutic Strategy in HNSCC.Smoking status regulates a novel panel of PIWI-interacting RNAs in head and neck squamous cell carcinoma.Effect of actionable somatic mutations on racial/ethnic disparities in head and neck cancer prognosis.The data of establishing a three-dimensional culture system for in vitro recapitulation and mechanism exploration of tumor satellite formation during cancer cell transition.Genomic characterization of human papillomavirus-positive and -negative human squamous cell cancer cell lines.Novel DNA targeted therapies for head and neck cancers: clinical potential and biomarkers.JARID1 Histone Demethylases: Emerging Targets in Cancer.Deciphering the Role of the Barr Body in Malignancy: An insight into head and neck cancer.High-Content Screening Comparison of Cancer Drug Accumulation and Distribution in Two-Dimensional and Three-Dimensional Culture Models of Head and Neck Cancer.AKT1 restricts the invasive capacity of head and neck carcinoma cells harboring a constitutively active PI3 kinase activity.Targeting JARID1B's demethylase activity blocks a subset of its functions in oral cancer.[Preclinical models in head and neck tumors : Evaluation of cellular and molecular resistance mechanisms in the tumor microenvironment].BET inhibition overcomes receptor tyrosine kinase-mediated cetuximab resistance in HNSCC.High-throughput testing in head and neck squamous cell carcinoma identifies agents with preferential activity in human papillomavirus-positive or negative cell lines.EGFR overexpression is not common in patients with head and neck cancer. Cell lines are not representative for the clinical situation in this indication.Tumors of the upper aerodigestive tractTumor associated macrophages induce epithelial to mesenchymal transition via the EGFR/ERK1/2 pathway in head and neck squamous cell carcinoma
P2860
Q26801410-8C9F412A-047C-4EDE-ACB8-C22A2667E985Q27329648-F0F9779E-1401-4429-9737-A71856B96C4FQ27853171-DEA3DD0D-9708-4E78-B29D-39272B543C79Q28084645-9731BEE9-D0D7-4862-9E12-1807B0BD24F4Q30278790-4C19289B-CBA6-46D2-9F79-77EC50A760AFQ33924908-9B876A6E-9857-4C15-B3D6-97BBD991FF72Q34619156-C7D36D92-AAE1-4BEC-BA21-0922520B8AF6Q35087559-4E88FEBE-215A-4FD1-8476-F05C736E4161Q36021572-74079560-2F07-4461-9CCE-0C1C1B62441BQ36297745-EBCDE3AE-047B-4AA7-BB1E-C263C89F065FQ36693061-22710399-347C-4D9F-B4B1-FF138C5194A1Q37027400-81D4E28C-A8F0-426B-BA3F-72075086028FQ37317404-A43D5BF2-D8C0-4627-84B9-ADCF9073DBFCQ37478633-0612461D-4BD2-448C-89D8-DD6F39D6A6C4Q38245688-303CCD24-B767-489B-89BD-ABA68D0CEABAQ38586956-26B70150-135B-43B4-B470-9216A3A90154Q38636694-54E7C95E-BFFE-4D37-BA41-E3F1449E3CB9Q38704070-31DACADE-7962-4178-89A2-5C8CB61510BFQ38707821-88C6190B-E817-4480-BBAA-92F1A6B8C13FQ38818008-E0E8C8B0-6E77-4D66-953D-D9DF5C379079Q39008207-E0C53748-E822-4856-8B78-F843E2A9B573Q39877713-6CA088E2-69CB-4F9F-979D-0521DA3A2277Q42655185-3A8108E7-52A8-4B79-9677-1C4560B94DD5Q44444441-2690870D-4960-4644-ADBD-549D480B5164Q45790068-2FB5C729-A4BB-4B24-8ABD-CD38263C6697Q47730101-2039DD39-38E2-48A5-B9FF-2B272276AC40Q49458339-9D868FCC-8054-44DD-8B08-B4AD576E5810Q50032174-2C1551A8-9BEC-45FF-BD89-9D3B2587DF47Q51736090-FC675083-DD01-4AC9-9D3A-8993107B05ACQ52672974-E8EA31D9-08EA-4461-A61D-D0170AB85779Q52815753-78B186A4-E2B8-48B1-826F-85F0DBCB3EB3Q54978430-DCEEAE6D-54D9-46AC-A620-7FC7B76A65A7Q55027478-984503B0-B8D7-4019-83C1-A29CE9DCCFAFQ55502873-17A278D3-1480-45A3-99D7-D1CE60B96DCEQ58426138-FEDD9D9C-D7AE-4736-A221-65086CA32C10Q58767635-4A8DD606-EA16-4F21-B03D-3F89E699293E
P2860
Genomic analysis of head and neck squamous cell carcinoma cell lines and human tumors: a rational approach to preclinical model selection.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 14 January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Genomic analysis of head and n ...... o preclinical model selection.
@en
Genomic analysis of head and n ...... o preclinical model selection.
@nl
type
label
Genomic analysis of head and n ...... o preclinical model selection.
@en
Genomic analysis of head and n ...... o preclinical model selection.
@nl
prefLabel
Genomic analysis of head and n ...... o preclinical model selection.
@en
Genomic analysis of head and n ...... o preclinical model selection.
@nl
P2093
P2860
P50
P1476
Genomic analysis of head and n ...... to preclinical model selection
@en
P2093
John S Wawrose
Noah D Peyser
William E Gooding
P2860
P304
P356
10.1158/1541-7786.MCR-13-0396
P577
2014-01-14T00:00:00Z